Ana-Marija Milenković-Grišić (Ana-Marija Grisic)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Transforming Growth Factor

Systematic Review

Metastatic Colorectal Cancer

Top Venues

CPT: pharmacometrics & systems pharmacology

Clinical pharmacology and therapeutics

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Ana-Marija Milenković-Grišić, Siobhán Hayes, Colm Farrell, Yoshihiro Kuroki, Mauro Bertolino, Karthik Venkatakrishnan, Pascal Girard
Model-informed Evidence for Clinical Non-inferiority of Every-2-Weeks Versus Standard Weekly Dosing Schedule of Cetuximab in Metastatic Colorectal Cancer. Clinical pharmacology and therapeutics (2024)
Ana-Marija Milenković-Grišić, Nadia Terranova, Diane R Mould, Yulia Vugmeyster, Thomas Mrowiec, Andreas Machl, Pascal Girard, Karthik Venkatakrishnan, Akash Khandelwal
Tumor growth inhibition modeling in patients with second line biliary tract cancer and first line non-small cell lung cancer based on bintrafusp alfa trials. CPT: pharmacometrics & systems pharmacology (2023)
Han Liu, Ana-Marija Milenković-Grišić, Sreenath M Krishnan, Siv Jonsson, Lena E Friberg, Pascal Girard, Karthik Venkatakrishnan, Yulia Vugmeyster, Akash Khandelwal, Mats O Karlson
A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancer. CPT: pharmacometrics & systems pharmacology (2023)
Ana-Marija Milenković-Grišić, Karthik Venkatakrishnan, Jonathan L French, Akash Khandelwal
Variable or Variate? A Conundrum in Pharmacometrics Exposure-Response Models. CPT: pharmacometrics & systems pharmacology (2022)
Ana-Marija Milenković-Grišić, Karthik Venkatakrishnan, Jonathan L French, Akash Khandelwal
Variable or variate? A conundrum in pharmacometrics exposure-response models. CPT: pharmacometrics & systems pharmacology 12 (2) (2022)
Akash Khandelwal, Ana-Marija Milenković-Grišić, Jonathan L French, Karthik Venkatakrishnan
Pharmacometrics Golems: Exposure-Response Models in Oncology. Clinical pharmacology and therapeutics 112 (5) (2022)
Ana-Marija Milenković-Grišić, Karthik Venkatakrishnan, Jonathan L French, Akash Khandelwal
Variable or variate? A conundrum in pharmacometrics exposure-response models. CPT: pharmacometrics & systems pharmacology (2022)
Ana-Marija Milenković-Grišić, Karthik Venkatakrishnan, Jonathan L French, Akash Khandelwal
Variable or variate? A conundrum in pharmacometrics exposure-response models. CPT: pharmacometrics & systems pharmacology 12 (2) (2022)
Ana-Marija Milenković-Grišić, Karthik Venkatakrishnan, Jonathan L French, Akash Khandelwal
Variable or variate? A conundrum in pharmacometrics exposure-response models. CPT: pharmacometrics & systems pharmacology 12 (2) (2022)
Ana-Marija Milenković-Grišić, Alexander Eser, Wilhelm Huisinga, Walter Reinisch, Charlotte Kloft
Quantitative relationship between infliximab exposure and inhibition of C-reactive protein synthesis to support inflammatory bowel disease management. British journal of clinical pharmacology 87 (5) (2020)